Table 1.

Distribution of T-lymphocyte subsets (mean ± SE) in DLBCL patients at baseline and after three cycles of chemotherapy

Group	N	CD3 + T cells (%)	CD3 + CD4 + T cells (%)	CD3 + CD8 + T cells (%)	Ratio of CD4 + /CD8 +	CD4 + /CD25 + T cells (%)
DLBCL patients at baseline	56	72.09 ± 3.16	32.31 ± 3.65	37.53 ± 6.46	0.85 ± 0.49	5.48 ± 4.96
DLBCL after three cycles of chemotherapy	56	71.24 ± 6.2	34.09 ± 4.63	32.51 ± 5.25	1.06 ± 0.87	8.32 ± 3.54
Healthy controls	26	72.90 ± 5.83	41.78 ± 4.23	28.51 ± 2.14	1.47 ± 0.27	3.68 ± 1.03